Skip to main content
ConductScienceScienceDex

Edward B Garon

NIH Rank #14555
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2055300Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#14,555
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Edward B Garon. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Edward B Garon as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA276917-02R01
    HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
    University of California, Los Angeles
    $592.4K
    award amount
  • 3R01CA276917-02S1R01
    HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
    University of California, Los Angeles
    $225.1K
    award amount
  • 5R21CA277172-02R21
    Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
    University of California, Los Angeles
    $209.9K
    award amount

Award organization

Organizations that administered FY2024 awards listing Edward B Garon as a PI.

FY2024 award administered by University of California, Los Angeles (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    R01 Grant Holder
  5. 2026
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Edward B Garon.

Bin Liu
University of California, Los Angeles
1
shared award

Explore further

Find collaborators for Edward B Garon

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →